Silihan lan utang jangka dawa perusahaan: TELA Bio, Inc. (TELA)

The current price chart for TELA Bio, Inc. (TELA) reflects the performance of the innovative tissue restoration implant manufacturer, whose unique risk-minimization methodology enables the company to maintain pricing power. Stable product demand ensures a consistent cash flow and steady operational growth. Meanwhile, long-term debt stands at 0.00, and the development strategy relies on in-house R&D supplemented by the partial use of external laboratories.

Long-term debt reflects the aggregate of obligations with maturities exceeding one year, allowing for an assessment of the capital structure's stability and the business's financial leverage. By analyzing the company's long-term borrowings, an investor can discern the balance between investment growth and debt load, which is critical for TELA Bio, Inc. (TELA) as it scales bio-implant sales amid stable demand in elective surgery.